Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study |
Sickle Cell Disease | Phase4 |
Belgium Brazil Colombia Germany Italy Lebanon Oman Spain Turkey United States View All
|
NCT04657822 |
|
Asciminib RMP Study |
Chronic Myeloid Leukemia | Korea, Republic of | NCT05943522 | |
|
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis |
Multiple Sclerosis | Phase3 |
France Germany Mexico Spain Ukraine United Kingdom United States View All
|
NCT01892722 |
|
CAR-T Long Term Follow Up (LTFU) Study |
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program | Phase3 |
Australia Austria Belgium Canada Denmark Finland France Germany Israel Italy Japan Norway Singapore Spain Taiwan United Kingdom United States View All
|
NCT02445222 |
|
Asciminib Roll-over Study |
Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase4 |
Austria Brazil Bulgaria Canada China Czechia Denmark France Germany Italy Korea, Republic of Mexico Poland Romania Russian Federation Spain Turkey United Kingdom United States View All
|
NCT04877522 |
|
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN |
IC-MPGN | Phase3 |
Argentina Brazil Canada Czechia France Germany India Israel Italy Japan Poland Spain Switzerland Turkey United Kingdom United States Vietnam View All
|
NCT05755386 |
|
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting |
Hormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA Mutation |
Italy Spain |
NCT04967248 | |
|
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG. |
Generalized Myasthenia Gravis | Phase3 |
Greece Italy Japan Poland Portugal Spain United Kingdom United States View All
|
NCT06517758 |
|
A 24-week rPMS Study in Real-world Setting for Enerzair |
Asthma | Korea, Republic of | NCT05274425 | |
|
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC. |
Non-Small Cell Lung Carcinoma | Phase4 | India | NCT05110196 |